Development
Dolby Laboratories, Inc.
DLB
$72.56
$0.580.81%
NYSE
| 12/29/2023 | 09/29/2023 | 06/30/2023 | 03/31/2023 | 12/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 1.28B | 1.30B | 1.29B | 1.28B | 1.24B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.28B | 1.30B | 1.29B | 1.28B | 1.24B |
| Cost of Revenue | 150.18M | 152.57M | 154.19M | 148.64M | 143.10M |
| Gross Profit | 1.13B | 1.15B | 1.13B | 1.13B | 1.09B |
| SG&A Expenses | 617.83M | 615.84M | 601.83M | 591.31M | 616.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.04B | 1.04B | 1.02B | 997.27M | 1.02B |
| Operating Income | 238.28M | 259.81M | 268.20M | 281.33M | 220.62M |
| Income Before Tax | 230.90M | 250.05M | 271.99M | 297.65M | 223.82M |
| Income Tax Expenses | 41.13M | 48.41M | 52.50M | 54.95M | 40.48M |
| Earnings from Continuing Operations | 189.78 | 201.64 | 219.50 | 242.70 | 183.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.52M | -988.00K | -269.00K | -276.00K | 112.00K |
| Net Income | 188.26M | 200.66M | 219.23M | 242.42M | 183.45M |
| EBIT | 238.28M | 259.81M | 268.20M | 281.33M | 220.62M |
| EBITDA | 319.56M | 342.37M | 348.71M | 364.35M | 304.76M |
| EPS Basic | 1.97 | 2.09 | 2.28 | 2.51 | 1.87 |
| Normalized Basic EPS | 1.82 | 1.91 | 1.92 | 1.96 | 1.50 |
| EPS Diluted | 1.93 | 2.06 | 2.25 | 2.47 | 1.85 |
| Normalized Diluted EPS | 1.79 | 1.88 | 1.89 | 1.94 | 1.48 |
| Average Basic Shares Outstanding | 382.56M | 383.08M | 384.46M | 389.02M | 394.54M |
| Average Diluted Shares Outstanding | 389.87M | 389.48M | 390.27M | 394.28M | 399.69M |
| Dividend Per Share | 1.14 | 1.11 | 1.08 | 1.06 | 1.04 |
| Payout Ratio | 56.35% | 51.53% | 46.45% | 41.71% | 54.87% |